Clinical Decision Support Systems Market Assessment: Evaluating Cost-Effectiveness
Clinical Decision Support Systems Market Growth & Trends
The global clinical decision support systems market size is anticipated to reach USD 10.71 billion by 2030 and is projected to grow at a CAGR of 10.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. Government initiatives aimed at promoting the adoption and integration of Clinical Decision Support Systems (CDSS) are expected to drive market growth by incentivizing hospitals and healthcare organizations to deploy such solutions. For example, in April 2023, the U.S. Department of Health and Human Services (HHS) revised certification program rules to encourage greater utilization of clinical decision support tools. Furthermore, advancements in AI and cloud-based CDSS technologies are projected to accelerate market expansion. The implementation of cloud-based computing to enhance CDSS platforms and database management is also anticipated to positively influence market growth in the forecast period.
Access the Clinical Decision Support Systems Market Size, Share & Trends Analysis Report By Product (Standalone CDSS, Integrated EHR With CDSS), By Application (Drug-Drug Interactions), By Delivery Mode, By Component, By Region, And Segment Forecasts, 2024 - 2030
During the COVID-19 pandemic, various government and community organizations initiated efforts to bolster the healthcare infrastructure. These initiatives ranged from setting up frontline clinics by state authorities to mobilizing volunteer panels of medical professionals and deploying private telemedicine platforms. Clinical Decision Support Systems (CDSS) proved indispensable during this crisis, assisting physicians in making informed decisions at the point of care.
Consequently, market participants capitalized on this opportunity to address challenges and support frontline healthcare providers. For example, in May 2022, epocrates, a subsidiary of athenahealth, Inc., enhanced its clinical decision support tools to better manage the challenges posed by the COVID-19 pandemic.
Furthermore, several companies are actively implementing strategies to enhance their clinical decision support systems (CDSS) offerings, consolidating their position in the market. For example, in February 2024, Elsevier Health collaborated with OpenEvidence, a prominent provider of AI solutions customized for the medical domain, to launch ClinicalKey AI in the U.S. This collaboration involved integrating advanced medical content with generative artificial intelligence (AI) to assist clinicians in patient-care interactions.
Order your free sample copy of “Clinical Decision Support Systems Market Report 2024 - 2030, published by Grand View Research
Clinical Decision Support Systems Market Report Highlights
· Based on product, the standalone CDSS segment led the market with the largest revenue share of 30.85% in 2023, owing to its low cost. The segment is estimated to hold approximately 31.0% of the overall market by 2030
· Based on application, the drug allergy alerts segment led the market with the largest revenue share of 25.83% in 2023, owing to the rising burden of allergies
· Based on delivery mode, the on-premises segment held the market with the largest revenue share of 42.35% in 2023, owing to its high adoption rate by healthcare organizations
· Based on component, the services segment led the market with the largest revenue share of 42.49% in 2023, owing to high frequency of updating software and other maintenance services
· North America dominated the market with the revenue share of 43.76% in 2023, due to strong presence of market player and increasing government initiatives to promote efficient usage of clinical decision support tools
Key Clinical Decision Support Systems Company Insights
The global market is fairly competitive. These players are involved in new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other.
Key Clinical Decision Support Systems Companies:
The following are the leading companies in the clinical decision support systems market. These companies collectively hold the largest market share and dictate industry trends.
· McKesson Corporation
· Oracle (Cerner Corporation)
· Siemens Healthineers GmbH
· Allscripts Healthcare, LLC
· athenahealth, Inc.
· NextGen Healthcare Inc.
· Koninklijke Philips N.V
· IBM Corporation
· Agfa-Gevaert Group
· Wolters Kluwer N.V.
Explore Horizon, the world’s most expansive market research database
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian